These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9619157)

  • 1. Predictors of a medical-offset effect among patients receiving antidepressant therapy.
    Thompson D; Hylan TR; McMullen W; Romeis ME; Buesching D; Oster G
    Am J Psychiatry; 1998 Jun; 155(6):824-7. PubMed ID: 9619157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant adherence and medical resource use among managed care patients with anxiety disorders.
    Stein MB; Cantrell CR; Sokol MC; Eaddy MT; Shah MB
    Psychiatr Serv; 2006 May; 57(5):673-80. PubMed ID: 16675762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs associated with changes in antidepressant treatment in a managed care population with major depressive disorder.
    Schultz J; Joish V
    Psychiatr Serv; 2009 Dec; 60(12):1604-11. PubMed ID: 19952150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity.
    Barsky AJ; Orav EJ; Bates DW
    Arch Gen Psychiatry; 2005 Aug; 62(8):903-10. PubMed ID: 16061768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
    Revicki DA; Simon GE; Chan K; Katon W; Heiligenstein J
    J Fam Pract; 1998 Dec; 47(6):446-52. PubMed ID: 9866670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant medication use for primary care patients with and without medical comorbidities: a national electronic health record (EHR) network study.
    Gill JM; Klinkman MS; Chen YX
    J Am Board Fam Med; 2010; 23(4):499-508. PubMed ID: 20616292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antidepressant therapy on health care utilization and costs in primary care.
    Croghan TW; Lair TJ; Engelhart L; Crown WE; Copley-Merriman C; Melfi CA; Obenchain RL; Buesching DP
    Psychiatr Serv; 1997 Nov; 48(11):1420-6. PubMed ID: 9355169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antidepressant treatments on health service utilization and medical costs among patients with depression: a nationwide population-based retrospective cohort study in Taiwan.
    Su KP; Tang CH; Chang HC; Chiu WC; Lu N; Huang KC
    Int Clin Psychopharmacol; 2019 Jul; 34(4):170-178. PubMed ID: 30964763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictors of depression treatment in an international primary care study.
    Simon GE; Fleck M; Lucas R; Bushnell DM;
    Am J Psychiatry; 2004 Sep; 161(9):1626-34. PubMed ID: 15337653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geriatric depression, antidepressant treatment, and healthcare utilization in a health maintenance organization.
    Fischer LR; Wei F; Rolnick SJ; Jackson JM; Rush WA; Garrard JM; Nitz NM; Luepke LJ
    J Am Geriatr Soc; 2002 Feb; 50(2):307-12. PubMed ID: 12028213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia.
    White LA; Robinson RL; Yu AP; Kaltenboeck A; Samuels S; Mallett D; Birnbaum HG
    J Pain; 2009 Sep; 10(9):976-83. PubMed ID: 19556168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression.
    Simon GE; Katon WJ; VonKorff M; Unützer J; Lin EH; Walker EA; Bush T; Rutter C; Ludman E
    Am J Psychiatry; 2001 Oct; 158(10):1638-44. PubMed ID: 11578996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid depression and anxiety spectrum disorders.
    Gorman JM
    Depress Anxiety; 1996-1997; 4(4):160-8. PubMed ID: 9166648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population.
    McCombs JS; Nichol MB; Stimmel GL; Sclar DA; Beasley CM; Gross LS
    J Clin Psychiatry; 1990 Jun; 51 Suppl():60-9; discussion 70-1. PubMed ID: 2189876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacoeconomic study of the management of major depression: patients in a TennCare HMO.
    Smith W; Sherrill A
    Med Interface; 1996 Jul; 9(7):88-92. PubMed ID: 10159282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care costs associated with depressive and anxiety disorders in primary care.
    Simon G; Ormel J; VonKorff M; Barlow W
    Am J Psychiatry; 1995 Mar; 152(3):352-7. PubMed ID: 7864259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care utilization and expenditures of persons with diabetes comorbid with anxiety disorder: a national population-based cohort study.
    Huang CJ; Chiu HC; Hsieh HM; Yen JY; Lee MH; Chang KP; Li CY; Lin CH
    Gen Hosp Psychiatry; 2015; 37(4):299-304. PubMed ID: 25936674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the medical outcomes study.
    Wells KB; Katon W; Rogers B; Camp P
    Am J Psychiatry; 1994 May; 151(5):694-700. PubMed ID: 7909411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.